NARSAD Grantee Anne Schaefer, M.D, Ph.D., was named one of 51 recipients of the prestigious 2012 Director’s New Innovator Award from the National Institutes of Health (NIH).
Dr. Schaefer is an Assistant Professor of Neuroscience and Psychiatry at the Mount Sinai School of Medicine and was the recipient of a NARSAD Young Investigator Grant in 2010. Her research is focused on understanding how epigenetic mechanisms contribute to maintenance of specialized neuronal functions and their alteration in brain and behavior disorders. Epigenetics refers to events that affect how genes are expressed without actually altering DNA structure.
The NIH Director's New Innovator Award is part of NIH's commitment to increasing opportunities for new scientists. Its goal is to "support a small group of exceptionally creative early stage investigators who propose bold new approaches that have the potential to produce a major impact on a broad area of biomedical or behavioral research." Over the next five years, Dr. Schaefer will receive $1.5 million to further her studies on epigenetics. Her award will complement the works she is currently pursuing with her NARSAD Grant. (See link below).
Dr. Schaefer said of the award, “It’s an honor to receive the NIH Director's New Innovator Award. It will provide essential support for my nascent research group and increases the visibility of my research program, and may help me to recruit outstanding students and postdocs. It also indicates that my research program is well in tune with the highly competitive and innovative program of The Friedman Brain Institute.”
Read Dr. Schaefer's comments on her research made possible by her NARSAD Grant.